US 11530239
Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor
granted A61KA61K38/00A61P
Quick answer
US patent 11530239 (Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor) held by The Board of Regents of the University of Oklahoma expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00, A61P, A61P15/08, A61P35/00